Mercom Capital Group, llc, a global communications and research firm, released its report on funding and merger and acquisition (M&A) activity for the Digital Health (Healthcare Information Technology) sector for the first quarter of 2019. Mercom’s comprehensive report covers deals of all sizes from across the globe.
Venture capital (VC) funding, including private equity and corporate venture capital into Digital Health (Healthcare IT) companies in Q1 2019, came to $2 billion in 149 deals compared to $1.4 billion in 142 deals in Q4 2018. VC funding in Q1 2019 was down 19% compared to the same quarter of last year (Q1 2018) when nearly $2.5 billion was raised in 187 deals.
Digital Health companies have brought in over $37 billion in disclosed VC funding since 2010.
Total corporate funding for Digital Health companies - including VC, debt, and public market financing - totaled $2.2 billion in Q1 2019.
“Funding levels were down compared to last year in Digital Health in the absence of larger deals. M&A activity was also flat. However, Digital Health public equities experienced a turnaround in Q1 with 66% of them beating the S&P 500 compared to Q4 2018 when 63% of the equities we tracked performed below the S&P 500. Favorable market conditions have prompted several companies to announce IPO plans,” said Raj Prabhu, CEO of Mercom Capital Group.
The top funded categories in Q1 2019 were: $557 million raised by Data Analytics companies, mHealth Apps with $392 million, Telemedicine with $220 million, Healthcare Booking with $177 million, Clinical Decision Support with $107 million, Mobile Wireless with $90 million and $80 million for Healthcare IT Service Providers.
There were 48 early-round deals in Q1 2019.
The top VC deals in Q1 2019 included: $170 million raised by Doctolib, $100 million from Health Catalyst, $88 million raised by Calm, and $80 million by Taimei Medical Technology.
A total of 371 investors participated in funding deals in Q1 2019 compared to 412 investors in Q1 2018. There were 16 FDA and CE approvals issued to Digital Health companies in Q1 2019.
Digital Health VC funding deals were distributed across 17 countries in Q1 2019.
In Q1 2019, there were 45 M&A transactions (seven disclosed) involving Digital Health companies compared to 48 M&A transactions (13 disclosed) in Q1 2018.
Practice Management Solutions companies led M&A activity with five transactions followed by Data Analytics companies with four transactions. Companies providing Clinical Decision Support, Electronic Medical Records, and Emergency Department Information Systems had two transactions each. There was one transaction each recorded by companies offering Asset Tracking, Document Management, Long-Term and Post-Acute Care, and Medical Imaging.
The top disclosed M&A transactions included the $195 million acquisition of Voalte by Hill-Rom Holdings, followed by BioTelemetry’s acquisition of Geneva Healthcare for $65 million. Alphabet's Google acquired Fossil Group’s intellectual property related to a smartwatch technology currently under development for $40 million, Netmeds acquisition of KiViHealth for $10 million and Livongo Health’s acquisition of myStrength for $10 million.
A total of 610 companies and investors were covered in this report.
Venture capital (VC) funding, including private equity and corporate venture capital into Digital Health (Healthcare IT) companies in Q1 2019, came to $2 billion in 149 deals compared to $1.4 billion in 142 deals in Q4 2018. VC funding in Q1 2019 was down 19% compared to the same quarter of last year (Q1 2018) when nearly $2.5 billion was raised in 187 deals.
Digital Health companies have brought in over $37 billion in disclosed VC funding since 2010.
Total corporate funding for Digital Health companies - including VC, debt, and public market financing - totaled $2.2 billion in Q1 2019.
“Funding levels were down compared to last year in Digital Health in the absence of larger deals. M&A activity was also flat. However, Digital Health public equities experienced a turnaround in Q1 with 66% of them beating the S&P 500 compared to Q4 2018 when 63% of the equities we tracked performed below the S&P 500. Favorable market conditions have prompted several companies to announce IPO plans,” said Raj Prabhu, CEO of Mercom Capital Group.
The top funded categories in Q1 2019 were: $557 million raised by Data Analytics companies, mHealth Apps with $392 million, Telemedicine with $220 million, Healthcare Booking with $177 million, Clinical Decision Support with $107 million, Mobile Wireless with $90 million and $80 million for Healthcare IT Service Providers.
There were 48 early-round deals in Q1 2019.
The top VC deals in Q1 2019 included: $170 million raised by Doctolib, $100 million from Health Catalyst, $88 million raised by Calm, and $80 million by Taimei Medical Technology.
A total of 371 investors participated in funding deals in Q1 2019 compared to 412 investors in Q1 2018. There were 16 FDA and CE approvals issued to Digital Health companies in Q1 2019.
Digital Health VC funding deals were distributed across 17 countries in Q1 2019.
In Q1 2019, there were 45 M&A transactions (seven disclosed) involving Digital Health companies compared to 48 M&A transactions (13 disclosed) in Q1 2018.
Practice Management Solutions companies led M&A activity with five transactions followed by Data Analytics companies with four transactions. Companies providing Clinical Decision Support, Electronic Medical Records, and Emergency Department Information Systems had two transactions each. There was one transaction each recorded by companies offering Asset Tracking, Document Management, Long-Term and Post-Acute Care, and Medical Imaging.
The top disclosed M&A transactions included the $195 million acquisition of Voalte by Hill-Rom Holdings, followed by BioTelemetry’s acquisition of Geneva Healthcare for $65 million. Alphabet's Google acquired Fossil Group’s intellectual property related to a smartwatch technology currently under development for $40 million, Netmeds acquisition of KiViHealth for $10 million and Livongo Health’s acquisition of myStrength for $10 million.
A total of 610 companies and investors were covered in this report.
Advertisements